EPINEPHRINE

EPINEPHRINE was reported 66805 times

EPINEPHRINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NO DEVICE MALFUNCTION 60 0.9836
1 INJECTION SITE PALLOR 127 0.4019
2 VASCULAR ACCESS SITE COMPLICATION 99 0.3929
3 COAGULATION FACTOR DEFICIENCY 39 0.2422
4 INFUSION SITE DISCHARGE 340 0.1937
5 ADMINISTRATION SITE SWELLING 61 0.1877
6 INFUSION SITE MASS 174 0.1601
7 INFUSION SITE BRUISING 324 0.1499
8 INFUSION SITE PRURITUS 457 0.1447
9 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 148 0.1394
10 INFUSION SITE URTICARIA 93 0.1388
11 INJECTION SITE ANAESTHESIA 44 0.1362
12 LAGOPHTHALMOS 55 0.1345
13 HEREDITARY ANGIOEDEMA 1427 0.1328
14 INFUSION SITE HAEMORRHAGE 382 0.1160
15 INFUSION SITE SCAR 51 0.1151
16 INFUSION SITE RASH 146 0.1063
17 INJECTION SITE LACERATION 68 0.1061
18 INFUSION SITE SWELLING 664 0.1054
19 INFUSION SITE DISCOMFORT 99 0.0955
20 ACCIDENTAL EXPOSURE 389 0.0933
21 LIQUID PRODUCT PHYSICAL ISSUE 677 0.0927
22 STEROID DEPENDENCE 79 0.0900
23 INFUSION SITE NODULE 86 0.0895
24 DEVICE FAILURE 1362 0.0894
25 TOXIC ANTERIOR SEGMENT SYNDROME 97 0.0889
26 ALLERGY TO PLANTS 40 0.0875
27 CATARRH 79 0.0874
28 MULTIPLE ALLERGIES 639 0.0814
29 INFUSION SITE EXTRAVASATION 473 0.0759
30 MATERNAL EXPOSURE DURING DELIVERY 75 0.0757
31 ADMINISTRATION SITE PAIN 86 0.0746
32 INFUSION SITE ERYTHEMA 622 0.0737
33 INJECTION SITE COLDNESS 62 0.0731
34 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 66 0.0712
35 INFUSION SITE PAIN 909 0.0705
36 STRESS CARDIOMYOPATHY 404 0.0694
37 INCORRECT DRUG ADMINISTRATION RATE 279 0.0655
38 INFUSION SITE IRRITATION 84 0.0654
39 IMMUNISATION REACTION 47 0.0653
40 MAST CELL ACTIVATION SYNDROME 89 0.0634
41 INSURANCE ISSUE 960 0.0627
42 KOUNIS SYNDROME 139 0.0612
43 TRYPTASE INCREASED 43 0.0602
44 INFUSION SITE WARMTH 73 0.0595
45 ALLERGIC SINUSITIS 51 0.0594
46 VASOPLEGIA SYNDROME 97 0.0591
47 DEVICE INFUSION ISSUE 144 0.0580
48 INFUSION SITE DISCOLOURATION 51 0.0580
49 INJECTION SITE HYPOAESTHESIA 81 0.0566
50 SEASONAL ALLERGY 799 0.0564
51 INFUSION SITE OEDEMA 45 0.0538
52 INFECTED BITE 45 0.0530
53 VASOCONSTRICTION 46 0.0526
54 BURNS SECOND DEGREE 87 0.0495
55 INFUSION SITE REACTION 142 0.0475
56 ARTHROPOD STING 77 0.0462
57 POOR VENOUS ACCESS 467 0.0451
58 PHARYNGEAL SWELLING 436 0.0445
59 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 60 0.0444
60 SINUSITIS BACTERIAL 45 0.0427
61 SINUSITIS 4063 0.0396
62 RESTRICTIVE PULMONARY DISEASE 46 0.0392
63 EAR INFECTION 1038 0.0390
64 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 85 0.0387
65 INFUSION SITE INDURATION 55 0.0371
66 ALLERGY TO ANIMAL 39 0.0366
67 NASAL DISCHARGE DISCOLOURATION 50 0.0362
68 NOROVIRUS INFECTION 52 0.0360
69 PULSELESS ELECTRICAL ACTIVITY 150 0.0359
70 CHRONIC SINUSITIS 134 0.0357
71 OBSTRUCTION 140 0.0350
72 DISTRIBUTIVE SHOCK 78 0.0344
73 DERMATITIS CONTACT 391 0.0343
74 FOOD ALLERGY 261 0.0338
75 RESPIRATORY TRACT INFECTION 874 0.0335
76 ARTERIOSPASM CORONARY 134 0.0334
77 POST-ACUTE COVID-19 SYNDROME 41 0.0331
78 VEIN RUPTURE 54 0.0322
79 UPPER RESPIRATORY TRACT INFECTION 1486 0.0321
80 HYPOPNOEA 111 0.0320
81 EXPIRED DRUG ADMINISTERED 158 0.0319
82 BODY TEMPERATURE ABNORMAL 57 0.0309
83 IMMUNOGLOBULINS DECREASED 41 0.0298
84 CENTRAL VENOUS CATHETERISATION 90 0.0298
85 PRODUCT DISTRIBUTION ISSUE 272 0.0293
86 PRODUCT COLOUR ISSUE 150 0.0292
87 RHINITIS 235 0.0291
88 PHARYNGITIS STREPTOCOCCAL 313 0.0289
89 ANAESTHETIC COMPLICATION 77 0.0286
90 RESPIRATORY TRACT INFECTION VIRAL 66 0.0283
91 ANIMAL BITE 75 0.0281
92 CATHETER SITE PAIN 73 0.0281
93 RUBBER SENSITIVITY 43 0.0281
94 ANAPHYLACTIC REACTION 1540 0.0278
95 BRASH SYNDROME 39 0.0278
96 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 92 0.0278
97 GASTROENTERITIS VIRAL 488 0.0270
98 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 181 0.0266
99 EXTREMITY NECROSIS 46 0.0263
100 PARANASAL SINUS DISCOMFORT 99 0.0261
101 CARDIOGENIC SHOCK 370 0.0258
102 HYPERLACTACIDAEMIA 69 0.0257
103 IMPAIRED QUALITY OF LIFE 358 0.0249
104 STREPTOCOCCAL INFECTION 138 0.0248
105 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 63 0.0240
106 STRIDOR 70 0.0238
107 PERIPHERAL ISCHAEMIA 97 0.0237
108 SKIN ABRASION 111 0.0235
109 WEIGHT FLUCTUATION 243 0.0232
110 SKIN INFECTION 259 0.0231
111 TOOTH INFECTION 294 0.0223
112 BRONCHITIS 1641 0.0221
113 EYE INFECTION 248 0.0219
114 BRONCHIECTASIS 147 0.0218
115 MIDDLE EAR EFFUSION 48 0.0217
116 LYME DISEASE 72 0.0216
117 OXYGEN SATURATION ABNORMAL 61 0.0215
118 BLOOD IMMUNOGLOBULIN E INCREASED 52 0.0215
119 VASCULAR DEVICE INFECTION 95 0.0209
120 ORAL PRURITUS 48 0.0209
121 RHINOVIRUS INFECTION 81 0.0208
122 COMPARTMENT SYNDROME 54 0.0207
123 NEEDLE ISSUE 600 0.0206
124 HAEMODYNAMIC INSTABILITY 157 0.0206
125 INJECTION SITE INJURY 113 0.0204
126 RESPIRATORY ACIDOSIS 80 0.0203
127 VENTRICULAR HYPOKINESIA 65 0.0202
128 PRODUCT PACKAGING CONFUSION 49 0.0202
129 BLOOD IMMUNOGLOBULIN G DECREASED 50 0.0202
130 VIRAL INFECTION 670 0.0201
131 CORNEAL OEDEMA 45 0.0201
132 SKIN LACERATION 218 0.0200
133 GASTROINTESTINAL INFECTION 179 0.0199
134 HYPERCAPNIA 60 0.0199
135 ARTHROPOD BITE 147 0.0198
136 MENINGITIS ASEPTIC 89 0.0198
137 FORCED EXPIRATORY VOLUME DECREASED 55 0.0194
138 SUSPECTED COVID-19 64 0.0194
139 INFUSION SITE INFECTION 45 0.0193
140 UPPER-AIRWAY COUGH SYNDROME 159 0.0193
141 SINUS DISORDER 382 0.0193
142 RESPIRATORY SYNCYTIAL VIRUS INFECTION 166 0.0190
143 FOOD POISONING 102 0.0190
144 HORDEOLUM 81 0.0187
145 INFUSION RELATED REACTION 1225 0.0185
146 BLOOD LACTIC ACID INCREASED 95 0.0180
147 HAEMATOLOGICAL INFECTION 44 0.0180
148 VENTRICULAR FIBRILLATION 199 0.0179
149 PRODUCT ADMINISTRATION INTERRUPTED 140 0.0178
150 APLASTIC ANAEMIA 93 0.0178
151 KIDNEY INFECTION 344 0.0175
152 VENTRICULAR TACHYCARDIA 287 0.0174
153 SINUS PAIN 40 0.0171
154 GASTRIC INFECTION 65 0.0170
155 VENTRICULAR ARRHYTHMIA 62 0.0169
156 RHINITIS ALLERGIC 75 0.0168
157 PULSE ABSENT 79 0.0166
158 FEAR 445 0.0165
159 SINUS CONGESTION 219 0.0162
160 ALCOHOL POISONING 43 0.0160
161 ATYPICAL PNEUMONIA 48 0.0160
162 PRE-EXISTING CONDITION IMPROVED 100 0.0160
163 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 82 0.0160
164 MULTI-ORGAN FAILURE 275 0.0159
165 TENDERNESS 165 0.0158
166 TOOTH ABSCESS 160 0.0157
167 ASTHMA 1767 0.0156
168 ORAL INFECTION 61 0.0156
169 CARDIAC MURMUR 134 0.0155
170 ILLNESS 1594 0.0155
171 PHARYNGITIS 191 0.0154
172 LARYNGEAL OEDEMA 93 0.0151
173 COVID-19 2642 0.0150
174 RESPIRATORY TRACT CONGESTION 239 0.0150
175 PARANASAL SINUS HYPERSECRETION 57 0.0149
176 PSEUDOMONAS INFECTION 128 0.0149
177 LIGAMENT SPRAIN 146 0.0148
178 SWOLLEN TONGUE 461 0.0147
179 INJECTION SITE SCAR 42 0.0147
180 CONCUSSION 114 0.0147
181 PAROSMIA 111 0.0147
182 VITAMIN B12 DEFICIENCY 59 0.0146
183 POST PROCEDURAL INFECTION 118 0.0145
184 ANAPHYLACTIC SHOCK 363 0.0141
185 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 239 0.0141
186 MYASTHENIA GRAVIS 113 0.0140
187 SINUS TACHYCARDIA 198 0.0139
188 ISCHAEMIA 64 0.0139
189 BRAIN FOG 214 0.0136
190 POST-TRAUMATIC STRESS DISORDER 91 0.0136
191 ELECTROCARDIOGRAM ABNORMAL 106 0.0135
192 COVID-19 PNEUMONIA 158 0.0134
193 MOUTH SWELLING 77 0.0133
194 CYSTITIS 424 0.0133
195 BRONCHOSPASM 189 0.0132
196 BLOOD PRESSURE SYSTOLIC DECREASED 60 0.0132
197 PRODUCT QUALITY ISSUE 1782 0.0131
198 CANDIDA INFECTION 220 0.0130
199 LOCALISED INFECTION 315 0.0130
200 SENSITIVE SKIN 96 0.0130
201 THROAT TIGHTNESS 350 0.0129
202 INFLUENZA 1437 0.0129
203 ANGIOEDEMA 568 0.0128
204 LIMB INJURY 348 0.0128
205 VEIN DISORDER 64 0.0128
206 OBSTRUCTIVE AIRWAYS DISORDER 142 0.0128
207 ARTHRITIS INFECTIVE 59 0.0127
208 RENAL INJURY 375 0.0126
209 INJURY ASSOCIATED WITH DEVICE 257 0.0126
210 PRODUCTIVE COUGH 601 0.0126
211 PNEUMONIA VIRAL 40 0.0125
212 HYPERVOLAEMIA 62 0.0125
213 THROAT CLEARING 47 0.0125
214 BACTERIAL INFECTION 233 0.0125
215 FUNGAL INFECTION 415 0.0124
216 POST PROCEDURAL COMPLICATION 239 0.0124
217 ANHEDONIA 322 0.0122
218 RALES 71 0.0122
219 SHOCK 281 0.0122
220 WHEEZING 713 0.0120
221 NASOPHARYNGITIS 2216 0.0120
222 PHARYNGEAL OEDEMA 184 0.0119
223 CARDIAC ARREST 985 0.0119
224 SNORING 45 0.0119
225 GINGIVAL PAIN 94 0.0118
226 BLOOD PRESSURE DIASTOLIC DECREASED 87 0.0118
227 HAND FRACTURE 83 0.0117
228 BREATH SOUNDS ABNORMAL 57 0.0115
229 LIP SWELLING 384 0.0115
230 URINARY TRACT INFECTION 1958 0.0115
231 MIGRAINE 1092 0.0114
232 URTICARIA 1911 0.0114
233 NASAL CONGESTION 669 0.0114
234 BRADYCARDIA 603 0.0114
235 PARAESTHESIA ORAL 163 0.0113
236 MONOCYTE COUNT INCREASED 41 0.0113
237 EXPIRED PRODUCT ADMINISTERED 375 0.0113
238 VITAMIN D DEFICIENCY 110 0.0113
239 NEPHROGENIC ANAEMIA 52 0.0112
240 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2015 0.0112
241 ACIDOSIS 85 0.0111
242 PRODUCT DOSE OMISSION ISSUE 3270 0.0111
243 HEART RATE ABNORMAL 62 0.0111
244 SENSITIVITY TO WEATHER CHANGE 58 0.0110
245 ENDOPHTHALMITIS 66 0.0110
246 DEVICE RELATED INFECTION 169 0.0110
247 EAR DISORDER 50 0.0109
248 BLOOD PRESSURE ABNORMAL 216 0.0109
249 THERMAL BURN 77 0.0108
250 SUSPECTED OFF LABEL USE 49 0.0108
251 METABOLIC ACIDOSIS 344 0.0107
252 LEFT VENTRICULAR DYSFUNCTION 72 0.0107
253 SCRATCH 113 0.0107
254 STAPHYLOCOCCAL INFECTION 353 0.0107
255 PNEUMONIA BACTERIAL 98 0.0107
256 OROPHARYNGEAL DISCOMFORT 96 0.0106
257 AUTOIMMUNE THYROIDITIS 40 0.0106
258 SUPRAVENTRICULAR TACHYCARDIA 101 0.0105
259 DEVICE USE ISSUE 182 0.0104
260 ACCIDENTAL EXPOSURE TO PRODUCT 1065 0.0103
261 CARDIOTOXICITY 92 0.0103
262 NORMAL NEWBORN 56 0.0103
263 MUSCLE STRAIN 89 0.0103
264 NASAL POLYPS 50 0.0101
265 CATHETERISATION CARDIAC 45 0.0101
266 HEPARIN-INDUCED THROMBOCYTOPENIA 50 0.0101
267 MYOCARDIAL ISCHAEMIA 115 0.0101
268 SINUS HEADACHE 60 0.0101
269 FOOT FRACTURE 191 0.0101
270 INJECTION SITE DISCHARGE 54 0.0100
271 INTENTIONAL PRODUCT USE ISSUE 876 0.0100
272 TROPONIN INCREASED 76 0.0100
273 INJECTION SITE DISCOLOURATION 124 0.0099
274 SCAR 169 0.0099
275 INABILITY TO AFFORD MEDICATION 97 0.0098
276 ESCHERICHIA INFECTION 80 0.0097
277 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 166 0.0097
278 BRAIN INJURY 97 0.0097
279 HYPOXIA 340 0.0096
280 JOINT INJURY 206 0.0096
281 INFECTION 1389 0.0096
282 RESPIRATORY DISTRESS 264 0.0096
283 EAR PAIN 185 0.0095
284 LIGAMENT RUPTURE 42 0.0095
285 ATTENTION DEFICIT HYPERACTIVITY DISORDER 40 0.0095
286 SPUTUM DISCOLOURED 90 0.0095
287 POSTOPERATIVE WOUND INFECTION 64 0.0095
288 GINGIVITIS 51 0.0094
289 CIRCULATORY COLLAPSE 161 0.0094
290 ACUTE PULMONARY OEDEMA 53 0.0094
291 VENTRICULAR EXTRASYSTOLES 98 0.0094
292 PRODUCT DOSE OMISSION IN ERROR 266 0.0094
293 PERIORBITAL SWELLING 53 0.0094
294 UNEVALUABLE EVENT 709 0.0094
295 WOUND INFECTION 102 0.0093
296 TACHYCARDIA 827 0.0093
297 RESPIRATORY DISORDER 278 0.0093
298 RESPIRATION ABNORMAL 63 0.0091
299 SINUS BRADYCARDIA 88 0.0091
300 LIVE BIRTH 76 0.0091
301 INTESTINAL ISCHAEMIA 50 0.0091
302 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 473 0.0091
303 WRIST FRACTURE 108 0.0090
304 ATELECTASIS 87 0.0090
305 CONJUNCTIVITIS 167 0.0090
306 AUTOIMMUNE DISORDER 87 0.0089
307 HEART RATE INCREASED 883 0.0089
308 INJURY 623 0.0089
309 FLANK PAIN 83 0.0088
310 CHEST DISCOMFORT 905 0.0088
311 NASAL DISCOMFORT 70 0.0088
312 ACUTE RESPIRATORY DISTRESS SYNDROME 156 0.0088
313 ORAL CANDIDIASIS 116 0.0088
314 SLEEP APNOEA SYNDROME 167 0.0087
315 OROPHARYNGEAL PAIN 810 0.0087
316 OXYGEN SATURATION DECREASED 490 0.0087
317 SKIN NECROSIS 45 0.0087
318 SNEEZING 194 0.0086
319 THROAT IRRITATION 388 0.0086
320 VIRAL UPPER RESPIRATORY TRACT INFECTION 41 0.0086
321 PLEURISY 51 0.0086
322 TEMPERATURE INTOLERANCE 88 0.0085
323 HYPERAESTHESIA 70 0.0085
324 BODY HEIGHT DECREASED 91 0.0085
325 LACTIC ACIDOSIS 273 0.0084
326 ECZEMA 441 0.0084
327 DIVERTICULITIS 233 0.0084
328 CELLULITIS 422 0.0084
329 SARS-COV-2 TEST POSITIVE 110 0.0083
330 PULMONARY HAEMORRHAGE 65 0.0083
331 COUGH 2318 0.0083
332 HYPOTENSION 1658 0.0083
333 PNEUMONIA 2674 0.0083
334 BLOOD PRESSURE SYSTOLIC INCREASED 161 0.0082
335 HYPERSENSITIVITY 1531 0.0082
336 CONTUSION 794 0.0082
337 APHONIA 115 0.0082
338 RESPIRATORY RATE INCREASED 73 0.0082
339 FACIAL PARALYSIS 70 0.0082
340 NEPHROLITHIASIS 375 0.0082
341 SECRETION DISCHARGE 102 0.0081
342 MUSCULOSKELETAL DISCOMFORT 139 0.0081
343 IMPAIRED GASTRIC EMPTYING 110 0.0081
344 ORAL HERPES 157 0.0080
345 HEAD INJURY 253 0.0080
346 FACIAL PAIN 71 0.0079
347 SWELLING 744 0.0079
348 CYANOSIS 125 0.0079
349 EMPHYSEMA 80 0.0079
350 PNEUMOTHORAX 125 0.0079
351 RHINORRHOEA 508 0.0079
352 APNOEA 61 0.0078
353 ANKLE FRACTURE 121 0.0078
354 LOW BIRTH WEIGHT BABY 62 0.0078
355 BODY TEMPERATURE INCREASED 159 0.0078
356 BODY TEMPERATURE DECREASED 76 0.0077
357 CHILLS 905 0.0077
358 PULMONARY MASS 115 0.0077
359 PERIORBITAL OEDEMA 40 0.0077
360 CLOSTRIDIUM DIFFICILE INFECTION 167 0.0076
361 ATRIAL FLUTTER 61 0.0076
362 CARPAL TUNNEL SYNDROME 107 0.0076
363 BLOOD PRESSURE INCREASED 1168 0.0076
364 SPINAL OPERATION 94 0.0076
365 SPINAL DISORDER 72 0.0076
366 DERMATITIS ATOPIC 395 0.0075
367 MENINGITIS 50 0.0075
368 NERVE COMPRESSION 69 0.0075
369 ANURIA 64 0.0074
370 RESPIRATORY DEPRESSION 91 0.0074
371 MULTIPLE ORGAN DYSFUNCTION SYNDROME 209 0.0074
372 HYPOAESTHESIA ORAL 111 0.0074
373 HYPOVOLAEMIA 43 0.0073
374 MIDDLE INSOMNIA 137 0.0073
375 DYSPNOEA EXERTIONAL 274 0.0073
376 TORSADE DE POINTES 57 0.0073
377 SCOLIOSIS 45 0.0073
378 VITAMIN D DECREASED 62 0.0072
379 ACUTE RESPIRATORY FAILURE 139 0.0072
380 HEART RATE DECREASED 253 0.0072
381 PARALYSIS 103 0.0072
382 SWELLING OF EYELID 45 0.0072
383 PRODUCT PREPARATION ISSUE 47 0.0072
384 ASPERGILLUS INFECTION 47 0.0072
385 SWELLING FACE 466 0.0071
386 HEADACHE 4480 0.0071
387 GANGRENE 43 0.0071
388 BACK DISORDER 116 0.0071
389 BLOOD PRESSURE DECREASED 473 0.0071
390 DECUBITUS ULCER 58 0.0071
391 PULMONARY OEDEMA 318 0.0071
392 RIB FRACTURE 146 0.0071
393 EYELID PTOSIS 72 0.0071
394 PULMONARY THROMBOSIS 77 0.0071
395 CHOLECYSTITIS ACUTE 40 0.0071
396 UNRESPONSIVE TO STIMULI 182 0.0070
397 DECREASED ACTIVITY 76 0.0070
398 EYE SWELLING 262 0.0070
399 PRODUCT LABEL CONFUSION 41 0.0070
400 PRODUCT AVAILABILITY ISSUE 159 0.0070
401 DEVICE OCCLUSION 98 0.0070
402 WRONG PRODUCT ADMINISTERED 47 0.0069
403 GENERALISED TONIC-CLONIC SEIZURE 115 0.0069
404 PRODUCT LABEL ISSUE 47 0.0069
405 SKIN WARM 40 0.0069
406 FIBROMYALGIA 167 0.0069
407 ATRIOVENTRICULAR BLOCK 53 0.0068
408 ROTATOR CUFF SYNDROME 88 0.0068
409 ULCER 109 0.0068
410 FEELING JITTERY 130 0.0068
411 INJECTION SITE SWELLING 520 0.0068
412 MUSCULOSKELETAL CHEST PAIN 105 0.0068
413 TACHYPNOEA 92 0.0068
414 PULMONARY CONGESTION 89 0.0067
415 URINE OUTPUT DECREASED 59 0.0067
416 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 370 0.0067
417 WRONG DRUG ADMINISTERED 60 0.0067
418 BRAIN OEDEMA 85 0.0067
419 FEAR OF INJECTION 48 0.0067
420 EAR DISCOMFORT 69 0.0067
421 MITRAL VALVE INCOMPETENCE 76 0.0067
422 TOOTH FRACTURE 74 0.0067
423 MYDRIASIS 86 0.0067
424 ADRENAL INSUFFICIENCY 81 0.0067
425 EYE PRURITUS 224 0.0067
426 COAGULOPATHY 111 0.0067
427 MASS 93 0.0066
428 LUNG INFECTION 103 0.0066
429 COMPLICATION ASSOCIATED WITH DEVICE 96 0.0066
430 EYE INFLAMMATION 63 0.0066
431 HERPES ZOSTER 378 0.0066
432 PALLOR 179 0.0066
433 HERNIA 127 0.0066
434 RIGHT VENTRICULAR FAILURE 46 0.0066
435 PYREXIA 2254 0.0065
436 EJECTION FRACTION DECREASED 101 0.0065
437 MUSCLE TIGHTNESS 105 0.0065
438 NEURALGIA 157 0.0065
439 EPSTEIN-BARR VIRUS INFECTION 40 0.0064
440 PRODUCT USE ISSUE 1203 0.0064
441 ASPIRATION 70 0.0064
442 INTERVERTEBRAL DISC DEGENERATION 59 0.0064
443 POOR QUALITY SLEEP 136 0.0063
444 ACUTE MYOCARDIAL INFARCTION 186 0.0063
445 CARDIOMYOPATHY 93 0.0063
446 BLOOD PRESSURE FLUCTUATION 151 0.0063
447 LACRIMATION INCREASED 190 0.0063
448 SENSATION OF FOREIGN BODY 53 0.0063
449 ACCIDENTAL OVERDOSE 230 0.0063
450 PREMATURE DELIVERY 100 0.0063
451 ATRIOVENTRICULAR BLOCK COMPLETE 42 0.0063
452 WEIGHT DECREASED 1749 0.0063
453 HIATUS HERNIA 81 0.0062
454 DYSPNOEA 3536 0.0062
455 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 298 0.0062
456 OSTEOMYELITIS 112 0.0062
457 FURUNCLE 49 0.0062
458 INTENTIONAL DOSE OMISSION 176 0.0062
459 RENAL FAILURE 819 0.0062
460 ACUTE CORONARY SYNDROME 51 0.0062
461 BLOOD IRON DECREASED 73 0.0061
462 PALPITATIONS 720 0.0061
463 RESPIRATORY FAILURE 447 0.0061
464 EOSINOPHIL COUNT INCREASED 51 0.0061
465 HYSTERECTOMY 53 0.0061
466 VERTIGO 372 0.0061
467 NECK PAIN 340 0.0061
468 LYMPHOEDEMA 42 0.0061
469 FULL BLOOD COUNT ABNORMAL 64 0.0060
470 OEDEMA 328 0.0060
471 INFLUENZA LIKE ILLNESS 497 0.0060
472 THERAPY NON-RESPONDER 271 0.0060
473 FEELING COLD 167 0.0060
474 INJECTION SITE DISCOMFORT 63 0.0060
475 ARTHRITIS 470 0.0060
476 CYST 74 0.0060
477 PRODUCT USE IN UNAPPROVED INDICATION 1475 0.0059
478 BLOOD POTASSIUM DECREASED 178 0.0059
479 INJECTION SITE EXTRAVASATION 73 0.0059
480 BACTERAEMIA 70 0.0059
481 IMPAIRED WORK ABILITY 126 0.0059
482 BACK INJURY 64 0.0059
483 ANXIETY 1674 0.0059
484 DYSPHONIA 344 0.0059
485 PROCEDURAL COMPLICATION 45 0.0059
486 FALL 1949 0.0058
487 ROAD TRAFFIC ACCIDENT 244 0.0058
488 LYMPHADENOPATHY 205 0.0058
489 SCAB 66 0.0058
490 UPPER LIMB FRACTURE 115 0.0058
491 PROCEDURAL PAIN 160 0.0058
492 SKIN SWELLING 50 0.0058
493 PRURITUS 2211 0.0057
494 BLADDER DISORDER 57 0.0057
495 CHEST PAIN 1062 0.0057
496 SYSTEMIC LUPUS ERYTHEMATOSUS 203 0.0057
497 RENAL TUBULAR NECROSIS 56 0.0057
498 SEPSIS 635 0.0057
499 DISSEMINATED INTRAVASCULAR COAGULATION 80 0.0057
500 GASTROINTESTINAL DISORDER 509 0.0057
501 BLOOD MAGNESIUM DECREASED 49 0.0057
502 INTERVERTEBRAL DISC PROTRUSION 124 0.0057
503 PULMONARY HYPERTENSION 118 0.0057
504 NEUTROPHIL COUNT INCREASED 58 0.0057
505 WEIGHT INCREASED 1265 0.0056
506 HEAD DISCOMFORT 100 0.0056
507 MIOSIS 45 0.0056
508 HYPERLIPIDAEMIA 67 0.0056
509 PRESCRIBED OVERDOSE 108 0.0056
510 CATARACT 331 0.0056
511 LOWER RESPIRATORY TRACT INFECTION 252 0.0055
512 TRICUSPID VALVE INCOMPETENCE 44 0.0055
513 PAIN 3401 0.0055
514 LIMB DISCOMFORT 171 0.0055
515 SKELETAL INJURY 57 0.0055
516 LOSS OF CONSCIOUSNESS 706 0.0055
517 DISCOMFORT 336 0.0055
518 POST PROCEDURAL HAEMORRHAGE 64 0.0055
519 TUBULOINTERSTITIAL NEPHRITIS 103 0.0055
520 RASH MACULAR 192 0.0055
521 KNEE OPERATION 54 0.0055
522 JOINT DISLOCATION 58 0.0055
523 ELECTROCARDIOGRAM QT PROLONGED 196 0.0054
524 TINNITUS 250 0.0054
525 IRON DEFICIENCY ANAEMIA 50 0.0054
526 PRODUCT PRESCRIBING ISSUE 118 0.0054
527 BLOOD SODIUM DECREASED 102 0.0054
528 PELVIC FRACTURE 42 0.0054
529 PRODUCT ADMINISTRATION ERROR 109 0.0054
530 BURSITIS 65 0.0054
531 CARDIO-RESPIRATORY ARREST 224 0.0054
532 DRY EYE 267 0.0053
533 OCULAR DISCOMFORT 60 0.0053
534 SKIN CANCER 115 0.0053
535 HYPOTHERMIA 54 0.0053
536 PNEUMONIA ASPIRATION 133 0.0053
537 SKIN FISSURES 104 0.0053
538 THROMBOSIS 428 0.0053
539 THYROID DISORDER 82 0.0053
540 ATRIAL FIBRILLATION 515 0.0053
541 FATIGUE 4108 0.0053
542 GASTROOESOPHAGEAL REFLUX DISEASE 424 0.0053
543 INJECTION SITE URTICARIA 129 0.0053
544 BACK PAIN 1221 0.0053
545 PREGNANCY 105 0.0052
546 SLEEP DISORDER 370 0.0052
547 RASH PRURITIC 284 0.0052
548 SEPTIC SHOCK 228 0.0052
549 MATERNAL EXPOSURE DURING PREGNANCY 466 0.0052
550 LUNG DISORDER 256 0.0052
551 NERVE INJURY 58 0.0052
552 PRODUCT USE COMPLAINT 82 0.0052
553 FEELING HOT 319 0.0052
554 BLOOD UREA INCREASED 87 0.0052
555 SKIN HAEMORRHAGE 77 0.0052
556 DYSPHAGIA 492 0.0052
557 PERIPHERAL SWELLING 797 0.0052
558 HYPERSOMNIA 148 0.0052
559 IMMUNE SYSTEM DISORDER 68 0.0052
560 WOUND 144 0.0051
561 COLD SWEAT 90 0.0051
562 SENSORY LOSS 41 0.0051
563 HEART RATE IRREGULAR 115 0.0051
564 HYPERTENSION 1077 0.0051
565 RASH 2214 0.0051
566 ABSCESS 81 0.0051
567 SEIZURE 586 0.0051
568 RENAL IMPAIRMENT 426 0.0051
569 BIPOLAR DISORDER 55 0.0051
570 PRODUCT PACKAGING ISSUE 48 0.0050
571 LOWER LIMB FRACTURE 97 0.0050
572 STATUS EPILEPTICUS 57 0.0050
573 TOOTHACHE 91 0.0050
574 ERYTHEMA 1032 0.0050
575 EYE DISCHARGE 52 0.0050
576 ANAL INCONTINENCE 45 0.0050
577 INTENTIONAL OVERDOSE 320 0.0050
578 EXPOSURE DURING PREGNANCY 310 0.0050
579 FEEDING DISORDER 101 0.0050
580 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 44 0.0050
581 RED BLOOD CELL SEDIMENTATION RATE INCREASED 55 0.0050
582 CARDIOMEGALY 61 0.0050
583 SKIN DISCOLOURATION 227 0.0049
584 PRESYNCOPE 120 0.0049
585 EATING DISORDER 105 0.0049
586 PANIC ATTACK 179 0.0049
587 MUSCULAR WEAKNESS 557 0.0049
588 MENTAL STATUS CHANGES 136 0.0049
589 FREQUENT BOWEL MOVEMENTS 132 0.0049
590 THERAPY CHANGE 48 0.0049
591 GENERALISED OEDEMA 60 0.0048
592 SPINAL FRACTURE 97 0.0048
593 OBESITY 77 0.0048
594 TOOTH EXTRACTION 60 0.0048
595 EXOSTOSIS 44 0.0048
596 PERIPHERAL COLDNESS 66 0.0048
597 ABDOMINAL DISTENSION 500 0.0048
598 INJECTION SITE BRUISING 382 0.0048
599 ARRHYTHMIA 226 0.0048
600 CARDIAC DISORDER 445 0.0048
601 THERAPEUTIC RESPONSE SHORTENED 157 0.0047
602 RESTLESS LEGS SYNDROME 86 0.0047
603 RASH ERYTHEMATOUS 226 0.0047
604 DEHYDRATION 629 0.0047
605 SMALL INTESTINAL OBSTRUCTION 58 0.0047
606 HAEMATOMA 122 0.0047
607 GALLBLADDER DISORDER 84 0.0047
608 HAEMOPTYSIS 131 0.0047
609 CONDITION AGGRAVATED 1427 0.0047
610 ECONOMIC PROBLEM 71 0.0047
611 FLUSHING 476 0.0047
612 LACERATION 44 0.0047
613 INJECTION SITE PRURITUS 311 0.0046
614 COMA 221 0.0046
615 BURNING SENSATION 325 0.0046
616 DRUG INEFFECTIVE 6100 0.0046
617 INJECTION SITE ERYTHEMA 573 0.0046
618 SYNCOPE 462 0.0046
619 INJECTION SITE PAIN 1416 0.0046
620 PYELONEPHRITIS 40 0.0046
621 SURGERY 268 0.0046
622 CHOKING 89 0.0046
623 QUALITY OF LIFE DECREASED 61 0.0045
624 TOOTH DISORDER 101 0.0045
625 OSTEOPOROSIS 186 0.0045
626 HYPERTENSIVE CRISIS 50 0.0045
627 WHITE BLOOD CELL COUNT INCREASED 172 0.0045
628 MALAISE 1966 0.0045
629 INJECTION SITE HAEMATOMA 65 0.0045
630 ELECTROLYTE IMBALANCE 52 0.0045
631 INCREASED TENDENCY TO BRUISE 41 0.0045
632 LEUKAEMIA 42 0.0044
633 PAIN IN EXTREMITY 1311 0.0044
634 DIPLOPIA 115 0.0044
635 DEVICE MALFUNCTION 311 0.0044
636 PREMATURE BABY 133 0.0044
637 TREMOR 733 0.0044
638 SPEECH DISORDER 231 0.0044
639 HYPOKINESIA 64 0.0044
640 HYPOAESTHESIA 657 0.0044
641 VOMITING 2063 0.0044
642 EYELID OEDEMA 51 0.0044
643 LEUKOCYTOSIS 79 0.0044
644 LETHARGY 251 0.0044
645 ACCIDENT 52 0.0044
646 NAUSEA 3435 0.0043
647 IRRITABLE BOWEL SYNDROME 93 0.0043
648 RED BLOOD CELL COUNT DECREASED 124 0.0043
649 INJECTION SITE RASH 133 0.0043
650 SCIATICA 69 0.0043
651 DRUG EFFECT LESS THAN EXPECTED 64 0.0043
652 EPISTAXIS 323 0.0043
653 FLUID RETENTION 219 0.0043
654 DEEP VEIN THROMBOSIS 279 0.0043
655 NODULE 56 0.0043
656 CHOLECYSTECTOMY 49 0.0043
657 HEPATOMEGALY 42 0.0043
658 BLOOD CALCIUM DECREASED 48 0.0043
659 THERAPY INTERRUPTED 305 0.0043
660 MEDICATION ERROR 236 0.0042
661 INJECTION SITE HAEMORRHAGE 339 0.0042
662 INJECTION SITE IRRITATION 54 0.0042
663 PERICARDIAL EFFUSION 98 0.0042
664 PHOTOPHOBIA 79 0.0042
665 OCULAR HYPERAEMIA 199 0.0042
666 PULMONARY EMBOLISM 398 0.0042
667 PHOTOSENSITIVITY REACTION 69 0.0042
668 HYPERHIDROSIS 538 0.0042
669 NEOPLASM 48 0.0042
670 VITREOUS FLOATERS 41 0.0042
671 COORDINATION ABNORMAL 58 0.0042
672 THERAPEUTIC RESPONSE DECREASED 252 0.0042
673 RASH PAPULAR 93 0.0041
674 DEPRESSED LEVEL OF CONSCIOUSNESS 164 0.0041
675 EMOTIONAL DISTRESS 501 0.0041
676 DYSURIA 152 0.0041
677 SLUGGISHNESS 42 0.0041
678 SEROTONIN SYNDROME 79 0.0041
679 RECTAL HAEMORRHAGE 176 0.0041
680 DYSARTHRIA 154 0.0041
681 GASTROINTESTINAL PAIN 45 0.0041
682 ARTHRALGIA 1696 0.0041
683 GASTRITIS 107 0.0041
684 ABDOMINAL DISCOMFORT 682 0.0041
685 TRANSIENT ISCHAEMIC ATTACK 137 0.0041
686 INJECTION SITE REACTION 279 0.0041
687 HAEMORRHOIDS 79 0.0040
688 HEPATIC STEATOSIS 75 0.0040
689 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 136 0.0040
690 GOUT 72 0.0040
691 DEVICE ISSUE 359 0.0040
692 DIZZINESS 1995 0.0040
693 KNEE ARTHROPLASTY 84 0.0040
694 NIGHTMARE 138 0.0040
695 HYPOKALAEMIA 184 0.0040
696 TOXICITY TO VARIOUS AGENTS 670 0.0040
697 NERVOUS SYSTEM DISORDER 124 0.0040
698 INCORRECT PRODUCT ADMINISTRATION DURATION 86 0.0040
699 IMMUNODEFICIENCY 59 0.0040
700 SKIN DISORDER 132 0.0040
701 HIP FRACTURE 127 0.0039
702 DISABILITY 78 0.0039
703 SKIN LESION 108 0.0039
704 COLITIS 149 0.0039
705 DEVICE DEFECTIVE 68 0.0039
706 FEELING ABNORMAL 938 0.0039
707 SOMNOLENCE 788 0.0039
708 DERMATITIS 82 0.0039
709 TRANSFUSION 41 0.0039
710 DERMATITIS ALLERGIC 49 0.0039
711 PAIN IN JAW 110 0.0039
712 LYMPHOMA 60 0.0039
713 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 275 0.0039
714 MUSCLE SPASMS 700 0.0038
715 NERVOUSNESS 199 0.0038
716 RETCHING 81 0.0038
717 INCONTINENCE 40 0.0038
718 PARAESTHESIA 595 0.0038
719 SKIN REACTION 53 0.0038
720 INTRAOCULAR PRESSURE INCREASED 48 0.0038
721 NO ADVERSE EVENT 678 0.0037
722 BLOOD URINE PRESENT 71 0.0037
723 HYPERKALAEMIA 131 0.0037
724 NEUROPATHY PERIPHERAL 355 0.0037
725 DENTAL CARIES 41 0.0037
726 DEPRESSION 842 0.0037
727 HAEMATOCRIT DECREASED 73 0.0037
728 EYE DISORDER 121 0.0037
729 MENTAL DISORDER 160 0.0037
730 RENAL FAILURE ACUTE 156 0.0037
731 CHRONIC KIDNEY DISEASE 279 0.0037
732 BLISTER 206 0.0037
733 BASAL CELL CARCINOMA 57 0.0036
734 BLOOD TEST ABNORMAL 51 0.0036
735 INJECTION SITE INDURATION 47 0.0036
736 HAEMATOCHEZIA 200 0.0036
737 FACE OEDEMA 61 0.0036
738 ACUTE KIDNEY INJURY 553 0.0036
739 HYPOPHAGIA 92 0.0036
740 EYE PAIN 203 0.0036
741 EYE IRRITATION 207 0.0036
742 INTESTINAL OBSTRUCTION 135 0.0036
743 PLEURAL EFFUSION 217 0.0036
744 RENAL DISORDER 166 0.0036
745 NIGHT SWEATS 114 0.0035
746 ABDOMINAL PAIN 823 0.0035
747 DEVICE LEAKAGE 153 0.0035
748 INJECTION SITE MASS 130 0.0035
749 COLITIS ULCERATIVE 157 0.0035
750 END STAGE RENAL DISEASE 64 0.0035
751 MEMORY IMPAIRMENT 480 0.0035
752 OSTEOARTHRITIS 148 0.0035
753 GLAUCOMA 67 0.0035
754 EXPOSURE VIA SKIN CONTACT 90 0.0035
755 ABDOMINAL PAIN UPPER 710 0.0034
756 MACULAR DEGENERATION 41 0.0034
757 OFF LABEL USE 3005 0.0034
758 BALANCE DISORDER 296 0.0034
759 ADVERSE REACTION 45 0.0034
760 SKIN EXFOLIATION 286 0.0034
761 BLOOD POTASSIUM INCREASED 55 0.0034
762 DEPRESSED MOOD 178 0.0034
763 FLUID OVERLOAD 49 0.0034
764 INJECTION SITE WARMTH 69 0.0034
765 OEDEMA PERIPHERAL 407 0.0033
766 DRY SKIN 445 0.0033
767 TENDON RUPTURE 41 0.0033
768 OSTEOPENIA 50 0.0033
769 INCORRECT ROUTE OF DRUG ADMINISTRATION 117 0.0033
770 HAEMORRHAGE 341 0.0033
771 ORAL PAIN 73 0.0033
772 THIRST 58 0.0032
773 RESPIRATORY ARREST 89 0.0032
774 GASTROENTERITIS 47 0.0032
775 MYALGIA 547 0.0032
776 ENCEPHALOPATHY 79 0.0032
777 HOSPITALISATION 494 0.0032
778 HAEMATEMESIS 81 0.0032
779 THERAPEUTIC RESPONSE UNEXPECTED 143 0.0032
780 ASTHENIA 1191 0.0032
781 TENDONITIS 49 0.0032
782 DIARRHOEA 2020 0.0031
783 HEMIPARESIS 53 0.0031
784 JOINT SWELLING 377 0.0031
785 INFLAMMATION 161 0.0031
786 TYPE 2 DIABETES MELLITUS 105 0.0031
787 CEREBROVASCULAR ACCIDENT 526 0.0031
788 PANCREATITIS 164 0.0031
789 HEPATIC FAILURE 93 0.0031
790 DIABETES MELLITUS 234 0.0031
791 THERAPEUTIC PRODUCT EFFECT DECREASED 137 0.0031
792 CRYING 111 0.0031
793 CARDIAC FAILURE CONGESTIVE 245 0.0030
794 BONE PAIN 178 0.0030
795 DRUG ADMINISTRATION ERROR 93 0.0030
796 SYRINGE ISSUE 53 0.0030
797 CHOLELITHIASIS 99 0.0030
798 PRODUCT PREPARATION ERROR 62 0.0030
799 PRURITUS GENERALISED 65 0.0030
800 LOCAL SWELLING 52 0.0030
801 VISION BLURRED 409 0.0030
802 RHABDOMYOLYSIS 124 0.0030
803 CHROMATURIA 67 0.0030
804 GAIT INABILITY 99 0.0030
805 INSOMNIA 786 0.0029
806 APHASIA 89 0.0029
807 GASTRIC ULCER 56 0.0029
808 POLLAKIURIA 122 0.0029
809 INCORRECT DOSE ADMINISTERED 667 0.0029
810 AGITATION 212 0.0029
811 ORAL DISCOMFORT 40 0.0029
812 HIP ARTHROPLASTY 44 0.0029
813 MUSCULOSKELETAL STIFFNESS 251 0.0029
814 DRY MOUTH 232 0.0029
815 TASTE DISORDER 58 0.0029
816 ADVERSE DRUG REACTION 256 0.0028
817 DYSPEPSIA 280 0.0028
818 LYMPHOCYTE COUNT DECREASED 50 0.0028
819 CONFUSIONAL STATE 452 0.0028
820 URINARY RETENTION 93 0.0028
821 SKIN ULCER 72 0.0028
822 COGNITIVE DISORDER 130 0.0028
823 GAIT DISTURBANCE 532 0.0028
824 IMPAIRED HEALING 91 0.0028
825 DRUG EFFECT INCOMPLETE 100 0.0028
826 ILL-DEFINED DISORDER 167 0.0027
827 HYPERGLYCAEMIA 100 0.0027
828 NEUROTOXICITY 48 0.0027
829 EMOTIONAL DISORDER 84 0.0027
830 PSYCHOMOTOR HYPERACTIVITY 45 0.0027
831 HAEMOGLOBIN DECREASED 278 0.0027
832 ARTHROPATHY 150 0.0027
833 UNDERDOSE 197 0.0027
834 BLOOD GLUCOSE DECREASED 129 0.0027
835 HOT FLUSH 201 0.0027
836 DRUG INTERACTION 421 0.0027
837 BLOOD CREATININE INCREASED 173 0.0026
838 URINARY INCONTINENCE 78 0.0026
839 JOINT STIFFNESS 69 0.0026
840 NEOPLASM MALIGNANT 175 0.0026
841 BLOOD ALKALINE PHOSPHATASE INCREASED 65 0.0026
842 SENSORY DISTURBANCE 42 0.0026
843 DECREASED APPETITE 604 0.0026
844 DRUG DOSE OMISSION BY DEVICE 203 0.0026
845 DEVICE BREAKAGE 105 0.0026
846 BONE DISORDER 47 0.0026
847 HEPATIC ENZYME INCREASED 175 0.0026
848 MUSCLE TWITCHING 59 0.0026
849 MUSCULOSKELETAL PAIN 134 0.0026
850 TREATMENT NONCOMPLIANCE 138 0.0025
851 DISTURBANCE IN ATTENTION 136 0.0025
852 VISUAL IMPAIRMENT 311 0.0025
853 UPPER GASTROINTESTINAL HAEMORRHAGE 42 0.0025
854 BLOOD GLUCOSE ABNORMAL 46 0.0025
855 BLOOD TRIGLYCERIDES INCREASED 44 0.0025
856 CONSTIPATION 542 0.0025
857 BLINDNESS 101 0.0025
858 PELVIC PAIN 45 0.0025
859 BLOOD LACTATE DEHYDROGENASE INCREASED 39 0.0025
860 FEMUR FRACTURE 76 0.0025
861 C-REACTIVE PROTEIN INCREASED 89 0.0024
862 FAECES DISCOLOURED 53 0.0024
863 HYPOTHYROIDISM 78 0.0024
864 MENTAL IMPAIRMENT 59 0.0024
865 CORONARY ARTERY DISEASE 73 0.0024
866 DYSGEUSIA 179 0.0024
867 DEAFNESS 63 0.0024
868 CARDIAC FAILURE 193 0.0024
869 ANAEMIA 458 0.0024
870 DISORIENTATION 95 0.0024
871 PHARMACEUTICAL PRODUCT COMPLAINT 62 0.0024
872 MYOCARDIAL INFARCTION 416 0.0024
873 SKIN IRRITATION 109 0.0024
874 FRACTURE 45 0.0024
875 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0024
876 CEREBRAL HAEMORRHAGE 85 0.0024
877 MOBILITY DECREASED 170 0.0024
878 OVERDOSE 509 0.0024
879 STOMATITIS 143 0.0024
880 INCREASED APPETITE 45 0.0024
881 HYPOGLYCAEMIA 114 0.0023
882 DELIRIUM 81 0.0023
883 ABDOMINAL PAIN LOWER 59 0.0023
884 SEDATION 61 0.0023
885 IRRITABILITY 138 0.0023
886 PULMONARY FIBROSIS 44 0.0023
887 FULL BLOOD COUNT DECREASED 46 0.0023
888 PNEUMONITIS 62 0.0023
889 GASTRIC DISORDER 78 0.0023
890 RESTLESSNESS 82 0.0022
891 FOETAL EXPOSURE DURING PREGNANCY 182 0.0022
892 MOVEMENT DISORDER 71 0.0022
893 PRODUCT COMPLAINT 56 0.0022
894 RASH GENERALISED 57 0.0022
895 RHEUMATOID ARTHRITIS 248 0.0022
896 AMNESIA 142 0.0022
897 LABORATORY TEST ABNORMAL 64 0.0022
898 BLOOD CHOLESTEROL INCREASED 101 0.0022
899 ANGINA PECTORIS 62 0.0022
900 CYTOKINE RELEASE SYNDROME 43 0.0021
901 MOUTH ULCERATION 45 0.0021
902 DRUG INTOLERANCE 206 0.0021
903 GASTROINTESTINAL HAEMORRHAGE 178 0.0021
904 HEPATIC CIRRHOSIS 40 0.0021
905 ASPARTATE AMINOTRANSFERASE INCREASED 113 0.0021
906 ALTERED STATE OF CONSCIOUSNESS 46 0.0021
907 PRODUCT DISPENSING ERROR 46 0.0021
908 SUICIDE ATTEMPT 128 0.0021
909 VISUAL ACUITY REDUCED 70 0.0021
910 ANGER 71 0.0021
911 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 422 0.0021
912 FEBRILE NEUTROPENIA 137 0.0021
913 PAIN OF SKIN 55 0.0020
914 DYSKINESIA 83 0.0020
915 ASCITES 60 0.0020
916 BLOOD BILIRUBIN INCREASED 55 0.0020
917 DYSSTASIA 59 0.0020
918 PRODUCT STORAGE ERROR 173 0.0020
919 THROMBOCYTOPENIA 220 0.0020
920 PANCREATITIS ACUTE 44 0.0020
921 HYPOACUSIS 84 0.0019
922 PSORIATIC ARTHROPATHY 79 0.0019
923 MULTIPLE SCLEROSIS 93 0.0019
924 MOOD ALTERED 53 0.0019
925 INTENTIONAL PRODUCT MISUSE 170 0.0019
926 ALANINE AMINOTRANSFERASE INCREASED 119 0.0019
927 DEVICE DELIVERY SYSTEM ISSUE 53 0.0019
928 SUICIDAL IDEATION 175 0.0019
929 MUCOSAL INFLAMMATION 50 0.0019
930 LIVER FUNCTION TEST INCREASED 41 0.0019
931 BLOOD CREATINE PHOSPHOKINASE INCREASED 54 0.0019
932 GENERAL PHYSICAL HEALTH DETERIORATION 217 0.0019
933 ABNORMAL BEHAVIOUR 74 0.0019
934 PLATELET COUNT DECREASED 199 0.0019
935 LIVER DISORDER 82 0.0018
936 PRODUCT PRESCRIBING ERROR 44 0.0018
937 EXTRA DOSE ADMINISTERED 74 0.0018
938 TREATMENT FAILURE 151 0.0018
939 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 85 0.0018
940 WRONG TECHNIQUE IN DRUG USAGE PROCESS 66 0.0018
941 FLATULENCE 103 0.0018
942 DRUG DOSE OMISSION 296 0.0018
943 ALOPECIA 346 0.0018
944 PSYCHOTIC DISORDER 51 0.0017
945 INCORRECT DOSE ADMINISTERED BY DEVICE 45 0.0017
946 HAEMATURIA 58 0.0017
947 SKIN BURNING SENSATION 121 0.0017
948 PRODUCT DOSE OMISSION 108 0.0017
949 ABORTION SPONTANEOUS 66 0.0016
950 DEMENTIA 46 0.0016
951 WHITE BLOOD CELL COUNT DECREASED 178 0.0016
952 DIABETIC KETOACIDOSIS 39 0.0016
953 LIVER FUNCTION TEST ABNORMAL 47 0.0016
954 CEREBRAL INFARCTION 39 0.0016
955 AGGRESSION 79 0.0016
956 INTERNATIONAL NORMALISED RATIO INCREASED 45 0.0016
957 CARDIOVASCULAR DISORDER 40 0.0016
958 AGEUSIA 39 0.0016
959 HEPATITIS 40 0.0016
960 ABNORMAL DREAMS 42 0.0015
961 DEATH 1284 0.0015
962 CONVULSION 85 0.0015
963 ACNE 112 0.0015
964 MOOD SWINGS 46 0.0014
965 HYPONATRAEMIA 81 0.0014
966 PSORIASIS 184 0.0014
967 THERAPY CESSATION 72 0.0014
968 BLOOD GLUCOSE INCREASED 261 0.0014
969 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 96 0.0013
970 DRUG EFFECT DECREASED 71 0.0013
971 OSTEONECROSIS 43 0.0013
972 DEVICE DISLOCATION 56 0.0013
973 NEUTROPHIL COUNT DECREASED 52 0.0013
974 PANCYTOPENIA 71 0.0013
975 HALLUCINATION 90 0.0012
976 PRODUCT SUBSTITUTION ISSUE 68 0.0012
977 ADVERSE EVENT 108 0.0012
978 BREAST CANCER 107 0.0011
979 DISEASE PROGRESSION 133 0.0011
980 NEUTROPENIA 151 0.0011
981 PLASMA CELL MYELOMA 43 0.0011
982 DEVICE DIFFICULT TO USE 72 0.0011
983 VAGINAL HAEMORRHAGE 47 0.0011
984 MULTIPLE SCLEROSIS RELAPSE 74 0.0011
985 LEUKOPENIA 54 0.0011
986 LUNG NEOPLASM MALIGNANT 43 0.0010
987 INTERSTITIAL LUNG DISEASE 49 0.0010
988 DISEASE RECURRENCE 42 0.0009
989 COMPLETED SUICIDE 49 0.0006
990 MALIGNANT NEOPLASM PROGRESSION 58 0.0006
991 DRUG ABUSE 46 0.0006
992 DRUG WITHDRAWAL SYNDROME 44 0.0005
993 DRUG DEPENDENCE 42 0.0003